Skip to main content
SpringerLink
Log in
Book cover

Kidney and Pancreas Transplantation pp 273–280Cite as

Perioperative and Anesthetic Management in Kidney and Pancreas Transplantation Management

  • Chapter
  • First Online:

  • 1772 Accesses

Part of the book series: Current Clinical Urology ((CCU))

Abstract

Comorbid medical and surgical conditions dictate the complexity of kidney and pancreas transplantation. Patients who present for kidney and/or pancreatic transplantation share similar perioperative concerns (risks associated with diabetes, hypertension, vascular access, and cardiovascular disease) in performing a successful transplantation. This chapter discusses specific anesthetic management issues related separately to kidney and pancreatic transplantation.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. SarinKapoor H, Kaur R, Kaur H. Anaesthesia for renal transplant surgery. Acta Anaesthesiol Scand 2007;51:1354–1367.

    Article  PubMed  CAS  Google Scholar 

  2. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32:S112–119.

    Article  PubMed  CAS  Google Scholar 

  3. Levey AS, Beto JA, Coronado BE, et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 1998;32:853–906.

    Article  PubMed  CAS  Google Scholar 

  4. US Renal Data System. 1998 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of diabetes, Digestive and Kidney Diseases. Available at http://www.usrds.org/adr_1998.htm.

  5. Charra B, Calemard M, Laurent G. Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. Am J Nephrol 1996;16:35–44.

    Article  PubMed  CAS  Google Scholar 

  6. Harnett JD, Kent GM, Foley RN, et al. Cardiac function and hematocrit level. Am J Kidney Dis 1995;25:S3–7.

    Article  PubMed  CAS  Google Scholar 

  7. Amann K, Gross ML, London GM, et al. hyperphosphataemia—a silent killer of patients with renal failure? Nephrol Dial Transplant 1999;14:2085–2087.

    Article  PubMed  CAS  Google Scholar 

  8. Philipson JD, Carpenter BJ, Itzkoff J, et al. Evaluation of cardiovascular risk for renal transplantation in diabetic patients. Am J Med 1986;81:630–634.

    Article  PubMed  CAS  Google Scholar 

  9. Schnuelle P, Lorenz D, Mueller A, et al. Donor catecholamine use reduces acute allograft rejection and improves graft survival after cadaveric renal transplantation. Kidney Int 1999;56:738–746.

    Article  PubMed  CAS  Google Scholar 

  10. Schnuelle P, Gottmann U, Hoeger S, et al. Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial. JAMA 2009;302:1067–1075.

    Article  PubMed  CAS  Google Scholar 

  11. Schnuelle P, Johannes vdW. Perioperative fluid management in renal transplantation: a narrative review of the literature. Transpl Int 2006;19:947–959.

    Article  PubMed  CAS  Google Scholar 

  12. Friedrich JO, Adhikari N, Herridge MS, et al. Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med 2005;142:510–524.

    PubMed  CAS  Google Scholar 

  13. Ho KM, Sheridan DJ. Meta-analysis of furosemide to prevent or treat acute renal failure. BMJ 2006;333:420.

    Article  PubMed  CAS  Google Scholar 

  14. Matas AJ, Bartlett ST, Leichtman AB, et al. Morbidity and mortality after living kidney donation, 1999–2001: survey of United States transplant centers. Am J Transplant 2003;3:830–834.

    PubMed  Google Scholar 

  15. Matas AJ. Transplantation using marginal living donors. Am J Kidney Dis 2006;47:353–355.

    Article  PubMed  Google Scholar 

  16. Boudville N, Prasad GV, Knoll G, et al. Meta-analysis: risk for hypertension in living kidney donors. Ann Intern Med 2006;145:185–196.

    PubMed  Google Scholar 

  17. O’Hara JF Jr, Bramstedt K, Flechner S, et al. Ethical issues surrounding high-risk kidney recipients: implications for the living donor. Prog Transplant 2007;17:180–182.

    PubMed  Google Scholar 

  18. Akpek E, Kayhan Z, Kaya H, et al. Epidural anesthesia for renal transplantation: a preliminary report. Transplant Proc 1999;31:3149–3150.

    Article  PubMed  CAS  Google Scholar 

  19. Tran TM, Ivanusic JJ, Hebbard P, et al. Determination of spread of injectate after ultrasound-guided transversus abdominis plane block: a cadaveric study. Br J Anaesth 2009;102:123–127.

    Article  PubMed  CAS  Google Scholar 

  20. Ragaller MJ, Theilen H, Koch T. Volume replacement in critically ill patients with acute renal failure. J Am Soc Nephrol 2001;12:S33–39.

    PubMed  Google Scholar 

  21. Cittanova ML, Leblanc I, Legendre C, et al. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996;348:1620–1622.

    Article  PubMed  CAS  Google Scholar 

  22. Huter L, Simon TP, Schuerholz T, et al. Hydroxyethyl starch impairs renal function and induces interstitial proliferation, macrophage infiltration and tubular damage in an isolated renal perfusion model. Crit Care 2009;13:R23.

    Article  PubMed  Google Scholar 

  23. Weimar W, Geerlings W, Bijnen AB, et al. A controlled study on the effect of mannitol on immediate renal function after cadaver donor kidney transplantation. Transplantation 1983;35:99–101.

    PubMed  CAS  Google Scholar 

  24. Tiggeler RG, Berden JH, Hoitsma AJ, et al. Prevention of acute tubular necrosis in cadaveric kidney transplantation by the combined use of mannitol and moderate hydration. Ann Surg 1985;201:246–251.

    Article  PubMed  CAS  Google Scholar 

  25. van Valenberg PL, Hoitsma AJ, Tiggeler RG, et al. Mannitol as an indispensable constituent of an intraoperative hydration protocol for the prevention of acute renal failure after renal cadaveric transplantation. Transplantation 1987;44:784–788.

    Article  PubMed  Google Scholar 

  26. Grundmann R, Kindler J, Meider G, et al. Dopamine treatment of human cadaver kidney graft recipients: a prospectively randomized trial. Klin Wochenschr 1982;60:193–197.

    Article  PubMed  CAS  Google Scholar 

  27. Walaszewski J, Rowinski W, Chmura A, et al. Decreased incidence of acute tubular necrosis after cadaveric donor transplantation due to lidocaine donor pretreatment and low-dose dopamine infusion in the recipient. Transplant Proc 1988;20:913.

    PubMed  CAS  Google Scholar 

  28. Dawidson I, Rooth P, Lu C, et al. Verapamil improves the outcome after cadaver renal transplantation. J Am Soc Nephrol 1991;2:983–990.

    PubMed  CAS  Google Scholar 

  29. Shilliday IR, Sherif M. Calcium channel blockers for preventing acute tubular necrosis in kidney transplant recipients. Cochrane Database Syst Rev 2005;(2):CD003421.

    Google Scholar 

  30. Hirose R, Xu F, Dang K, et al. Transient hyperglycemia affects the extent of ischemia-reperfusion-induced renal injury in rats. Anesthesiology 2008;108:402–414.

    Article  PubMed  CAS  Google Scholar 

  31. Lee HT, Ota-Setlik A, Fu Y, et al. Differential protective effects of volatile anesthetics against renal ischemia-reperfusion injury in vivo. Anesthesiology 2004;101:1313–1324.

    Article  PubMed  CAS  Google Scholar 

  32. Libman I, Songer T, LaPorte R. How many people in the U.S. have IDDM? Diabetes Care 1993;16:841–842.

    PubMed  CAS  Google Scholar 

  33. Sutherland DE. Pancreas transplants. Br J Surg 1994;81:2–4.

    Article  PubMed  CAS  Google Scholar 

  34. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. NEJM 1993;329:977–986.

    Article  Google Scholar 

  35. Light JA, Sasaki TM, Currier CB, et al. Successful long-term kidney-pancreas transplants regardless of C-peptide status or race. Transplantation 2001;71:152–154.

    Article  PubMed  CAS  Google Scholar 

  36. Robertson RP. Seminars in medicine of the Beth Israel Hospital, Boston. Pancreatic and islet transplantation for diabetes—cures or curiosities? NEJM 1992;327:1861–1868.

    Article  PubMed  CAS  Google Scholar 

  37. Sutherland DE, Gruessner RW, Gores PF, Brayman K, Wahoff D, Gruessner A. Pancreas transplantation: an update. Diabetes Metab Rev 1995;11:337–363.

    Article  PubMed  CAS  Google Scholar 

  38. Manske CL, Thomas W, Wang Y, et al. Screening diabetic transplant candidates for coronary artery disease: identification of a low risk subgroup. Kidney Int 1993;44:617–621.

    Article  PubMed  CAS  Google Scholar 

  39. Burgos LG, Ebert TJ, Asiddao C, et al. Increased intraoperative cardiovascular morbidity in diabetics with autonomic neuropathy. Anesthesiology 1989;70:591–597.

    Article  PubMed  CAS  Google Scholar 

  40. Hogan K, Rusy D, Springman SR. Difficult laryngoscopy and diabetes mellitus. Anesth Analg 1988;67:1162–1165.

    Article  PubMed  CAS  Google Scholar 

  41. Beebe DS, Belani KG, Yoo M, et al. Anesthetic considerations in pancreas transplantation. Based on a 1-year review. Surv Anesthesiol 1996;40:255.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesia, Cleveland Clinic, Cleveland, OH, USA

    Jerome F. O’Hara Jr.

Authors
  1. Jerome F. O’Hara Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Samuel A. Irefin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jerome F. O’Hara Jr. .

Editor information

Editors and Affiliations

  1. Glickman Urological & Kidney Institute, Children's Hospital of Cleveland Clinic, Euclid Ave. 9500, Cleveland, 44195, Ohio, USA

    T. R. Srinivas

  2. Glickman Urological & Kidney Institute, Cleveland Clinic, 9500 Euclid Avenue 9500, Cleveland, 44195, Ohio, USA

    Daniel A. Shoskes

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

O’Hara, J.F., Irefin, S.A. (2011). Perioperative and Anesthetic Management in Kidney and Pancreas Transplantation Management. In: Srinivas, T., Shoskes, D. (eds) Kidney and Pancreas Transplantation. Current Clinical Urology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-642-9_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-642-9_14

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60761-641-2

  • Online ISBN: 978-1-60761-642-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation